Takehisa Yamada

674 citations
45 papers · 560 indexed · h-index 12
Topics
Renal Diseases and Glomerulopathies (5 papers)Electrolyte and hormonal disorders (5 papers)Gastrointestinal motility and disorders (3 papers)

In The Last Decade

Takehisa Yamada

38 papers receiving 538 citations

Peers

Takehisa Yamada
Comparison fields: 5 of 100
  • Molecular Biology 272
  • Pulmonary and Respiratory Medicine 71
  • Nephrology 69
  • Oncology 63
  • Surgery 60
Replace Sumiko Odani with:
Sumiko Odani Japan
Morton Urivetzky United States
M.J. Foglietti France
Anna M. Milan United Kingdom
Shunchang Zhou China
Jialiang Liu China
Mayumi Hasegawa Japan
Huiyu Hu China
Zhenzhen Deng China
I‐Chieh Chen Taiwan
Takehisa Yamada relative to Sumiko Odani Japan Sumiko Odani's profile →
Citations per field
00.5×1.5×2.0×
Sumiko Odani · 1×
Citations per year

Countries citing papers authored by Takehisa Yamada

Since Specialization
Citations

This map shows the geographic impact of Takehisa Yamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehisa Yamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehisa Yamada more than expected).

Fields of papers citing papers by Takehisa Yamada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takehisa Yamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehisa Yamada. The network helps show where Takehisa Yamada may publish in the future.

Co-authorship network of co-authors of Takehisa Yamada

This figure shows the co-authorship network connecting the top 25 collaborators of Takehisa Yamada. A scholar is included among the top collaborators of Takehisa Yamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takehisa Yamada. Takehisa Yamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 8
4 2
5 6
6 10
7 7
8 4
9 24
10 3
11 4
12 18
13 1
14 1
15 24
16 18
17 73
18 8
19 3
20 9

About Takehisa Yamada

Takehisa Yamada is a scholar working on Nephrology, Gastroenterology and Orthodontics, having authored 45 papers that have together received 560 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (5 papers), Electrolyte and hormonal disorders (5 papers) and Gastrointestinal motility and disorders (3 papers). The work is most often cited by research in Nephrology (69 citations), Immunology and Allergy (37 citations) and Biotechnology (42 citations). Takehisa Yamada has collaborated with scholars based in Japan, United Kingdom and Canada. Frequent co-authors include Hiroshi Nonoguchi, Yoshio Terada, Fumiaki Marumo, Yoshimi Homma, Fumiaki Marumo, Tianxin Yang, Yasuhiro Yuasa, Osamu Nagata, Tsukasa Matsuda and Takahiro Adachi. Their work appears in journals such as Journal of Biological Chemistry, Water Research and Kidney International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026